However, the patients had significantly shorter OS and DFS time at an advanced stage (III + IV) (both p < 0.001), depicting a correlation between PABPC1 upregulation and NPC tumor progression. The gene discussed is PABPC1; the disease is nasopharyngeal carcinoma.